Depression screening and risk profile in diabetic patients

Culman, Mirela; Guja, Cristian; Mihai, Augustin; Serafinceanu, Cristian

doi:10.4323/rjlm.2013.197

Cited by 2 publications

(2 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data regarding the prevalence of depression and major depression, respectively as well as of anxiety and cognitive impairment in subjects with T2D in Romania is scarce. A study performed in patients with both type 1 diabetes (T1D) and T2D with poor metabolic control reported that 58% of them had significant elevated symptoms of depression, but data was not presented separately for patients with T2D (16).…”

Section: Introductionmentioning

confidence: 99%

Prevalence of Depression, Anxiety and Cognitive Impairment in Patients with Type 2 Diabetes from the Central Part of Romania

Zoltai

Berbecilă

Șular³

2016

Acta Medica Marisiensis

View full text Add to dashboard Cite

Objective: The aim of this study was to assess the prevalence of depression, anxiety and cognitive impairment in patients with type 2 diabetes (T2D).Material and methods: We conducted a cross-sectional study in patients with T2D. Depression and anxiety were assessed by questionnaires (PHQ-9, CES-D and GAD-7 respectively), cognitive function by the MoCA test. Additionally, 503 patients’ clinic charts were separately analyzed in order to compare the data recorded in the charts with that resulted from the active assessment.Results: In the screening study 216 subjects with T2D were included (62.2 ± 7.8 years old). 34.3% of them had depression and 7.4% presented major depression. 44.9% of patients with T2D had anxiety (9.2% major anxiety) and this was highly correlated with depression (OR: 21.139, 95%CI: 9.767-45.751; p<0.0001). Women had significantly higher prevalence of depression and anxiety compared to men (42.1% vs. 21.7%; p: 0.0021 and 51.1% vs. 34.9%; p: 0.02), but severe depression was similar between genders (9.0% vs. 4.8%; p: 0.29). Significantly more patients had depression and anxiety than recorded in their charts (34.3% vs. 13.9% and 44.9% vs. 9.3%, respectively; p<0.0001 for both). 69.0% of T2D patients had mild, 6.0% had moderate and none had severe cognitive dysfunction, respectively. Significantly more patients with depression and anxiety had mild and moderate cognitive impairment (p: 0.03 and p: 0.04, respectively).Conclusions: Patients with T2D had a high prevalence of comorbid depression, anxiety and cognitive impairment. Depression and anxiety were significantly more frequent in women. These conditions were under-evaluated and/or under-reported.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence of Depression, Anxiety and Cognitive Impairment in Patients with Type 2 Diabetes from the Central Part of Romania

Zoltai

Berbecilă

Șular³

2016

Acta Medica Marisiensis

View full text Add to dashboard Cite

show abstract

“…It is known, however, that the presence of diabetes influences the progression of cancer through different mechanisms, such as hyperglycemia, hyperinsulinemia and chronic inflammation associated with cellular proliferation [19][20][21][22][23][24].…”

Section: Resultsmentioning

confidence: 99%

Clinical Impact of Association Between Diabets and Lung Cancer

Mazilu¹,

Stănculeanu²,

Gheorghe³

et al. 2019

Rev. Chim.

View full text Add to dashboard Cite

The main objective of this analysis is to evaluate the impact of lung cancer and diabetes association on cancer treatment and outcome of lung cancer patients. Lung cancer, as well as diabetes mellitus, are two diseases with very high prevalence. Lung cancer, despite the improvement in diagnosis and therapeutic methods, is still the 1st cause of cancer-related deaths. The influence of diabetes on cancer patients survival is well established among patients with hepatic, pancreatic or breast cancer. Diabetes implication on lung cancer outcome is not well known. Several studies reported a negative impact, whereas other studies reported a better prognosis for these patients. Our study took place in the Oncology Department of the Clinical Emergency Hospital of Constanta, Romania. 80 patients with diagnosis of non-small cell lung cancer were elected to participate in this study; 29 patients had also diabetes. Selected patients were divided in 2 groups, one group of lung cancer and diabetes, and one group without diabetes. Features of the patients among both groups were analyzed. Our study showed that preexisting diabetes is an unfavorable factor, and has influence on lung cancer prognosis, treatment adhesion and quality of life. To amend the outcome of patients with lung cancer, a better evaluation of patients� co-morbidities, including diabetes mellitus, is required.

show abstract

Depression screening and risk profile in diabetic patients

Cited by 2 publications

References 24 publications

Prevalence of Depression, Anxiety and Cognitive Impairment in Patients with Type 2 Diabetes from the Central Part of Romania

Prevalence of Depression, Anxiety and Cognitive Impairment in Patients with Type 2 Diabetes from the Central Part of Romania

Clinical Impact of Association Between Diabets and Lung Cancer

Contact Info

Product

Resources

About